Using GEPIA for survival analysis of these 11 genes, showed that 6 genes (SUCLG1, PCK2, GLDC, SLC12A1, ATP1A1, PDHA1) had prognostic value in RCC patients, and may be involved in the carcinogenesis of the disease. Here, PCK2 is linked to renal cell adenocarcinoma.